Is Pier 1 Taking The Poison Pill?

Pier 1 has adopted a "poison pill" provision to try and stop a takeover bid.

Pier 1 is trying to protect itself from potential takeover bids. So, in order to do that, the company is invoking something known as a “poison pill” provision, also known as a “Rights Protection Agreement,” which protects the company from any single shareholder acquiring more than a 10 percent stake in Pier 1, according to MarketWatch.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    This comes after Global Capital LLC, a hedge fund, revealed last week that it had acquired a 9.5 percent stake in the home-goods retailer.

    The Rights Protection Agreement “may cause substantial dilution to anyone acquiring 10 percent or more of the company’s common stock, which may block or render more difficult a merger, tender offer or other business combination,” according to a statement from Pier 1.

    Although the new provision won’t outright prevent a takeover, it does attach to every common stock the right to buy a fraction of junior preferred stock at the price of $17.50, carrying the same voting rights as the common stock, thus watering down the influence of shareholders that hold a large percent of Pier 1’s stock.

    “The board feels it is important to ensure that all shareholders have the opportunity to realize the long-term value of the iconic Pier 1 Imports brand and to guard against coercive or unfair tactics to gain control of the company without paying all shareholders an appropriate premium,” Terry London, Pier 1’s chairman, said in a statement.